GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Gastroenterology, Elsevier BV, Vol. 162, No. 7 ( 2022-05), p. S-43-
    Type of Medium: Online Resource
    ISSN: 0016-5085
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Clinical Pathology, BMJ, Vol. 70, No. 3 ( 2017-03), p. 250-254
    Type of Medium: Online Resource
    ISSN: 0021-9746 , 1472-4146
    RVK:
    Language: English
    Publisher: BMJ
    Publication Date: 2017
    detail.hit.zdb_id: 2028928-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Cancer Prevention Research, American Association for Cancer Research (AACR), Vol. 11, No. 7 ( 2018-07-01), p. 403-412
    Abstract: About 5% of colorectal adenomas are estimated to progress to colorectal cancer. However, it is important to identify which adenomas actually carry a high risk of progression, because these serve as intermediate endpoints, for example, in screening programs. In clinical practice, adenomas with a size of ≥10 mm, villous component and/or high-grade dysplasia, called advanced adenomas, are considered high risk, although solid evidence for this classification is lacking. Specific DNA copy number changes are associated with adenoma-to-carcinoma progression. We set out to determine the prevalence of cancer-associated events (CAE) in advanced and nonadvanced adenomas. DNA copy number analysis was performed on archival tissues from three independent series of, in total, 297 adenomas (120 nonadvanced and 177 advanced) using multiplex ligation-dependent probe amplification or low-coverage whole-genome DNA sequencing. Alterations in two or more CAEs were considered to mark adenomas as high risk. Two or more CAEs were overall present in 25% (95% CI, 19.0–31.8) of advanced adenomas; 23% (11/48), 36% (12/33), and 23% (22/96) of the advanced adenomas in series 1, 2, and 3, respectively, and 1.7% (1/58) and 4.8% (3/62) of the nonadvanced adenomas, in series 1 and 2, respectively. The majority of advanced adenomas do not show CAEs, indicating that only a subset of these lesions is to be considered high risk. Nonadvanced adenomas have very low prevalence of CAEs, although those with CAEs should be considered high risk as well. Specific DNA copy number alterations may better reflect the true progression risk than the advanced adenoma phenotype. Cancer Prev Res; 11(7); 403–12. ©2018 AACR.
    Type of Medium: Online Resource
    ISSN: 1940-6207 , 1940-6215
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2018
    detail.hit.zdb_id: 2422346-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 3_Supplement ( 2017-02-01), p. A04-A04
    Abstract: Background: Colorectal adenomas are precursor lesions of colorectal cancer. About 5% of colorectal adenomas are estimated to progress to colorectal cancer (CRC). The currently used histo-pathological characteristics to identify adenomas at risk of malignant progression, i.e. scoring of size ≥ 10mm, villous component or high grade dysplasia, are not sufficiently sensitive and specific and prone to inter-observer variability. Integrating molecular markers reflecting the underlying biology of CRC into the current classification system is expected to better characterize adenomas at high-risk of progression. Aim: Here we compared the prevalence of genetic changes, in particular DNA copy number changes, between advanced and non-advanced adenomas. Methods: Formalin-fixed paraffin-embedded tissue samples from 121 patients (mean age 65.4±11.6, 52.9% male) with colorectal adenomas (63 non-advanced adenomas and 58 advanced adenomas) were retrospectively collected from the archives of the department of pathology of the VU - University medical center (VUmc), Amsterdam, the Netherlands. DNA was extracted and DNA copy number analysis was performed using Multiplex Ligation-dependent Probe Amplification (MLPA), focusing on 7 chromosomal regions previously associated with adenoma-to-carcinoma progression, namely 8p, 15q, 17p and 18q loss and 8q,13q and 20q gain (1). Comparison of DNA copy number aberrations between sub-groups was done using a Chi-square test, or Fisher's exact test when appropriate. For multivariate analysis logistic regression was used. Data analysis was performed using SPSS version 22 (IBM SPSS Statistics) and p-values below 0.05 were considered to be statistically significant (using two-sided tests). Results: Of the adenomas analyzed 23.1% (28/121) showed at least one gain or loss of the investigated chromosomal regions. Two or more chromosomal aberrations were present in 22.4 % (13/58) of the advanced adenomas and 1.6% (1/63) of the non-advanced adenomas (p=0,001). Since advanced colorectal adenomas are defined based on their histological characteristics ((tubulo)villous component and/or high degree dysplasia and/or ≥ 10mm), we searched for associations of these histological features with the analyzed chromosomal aberrations (CAE's). Multivariate analysis showed that only gains of 13q and 20q were significantly associated with adenomas ≥ 10mm (p=0.01 and p=0.003, respectively) and losses of 18q were significantly associated with high-grade dysplasia (p=0.04). Conclusion: Our data indicate that DNA copy number alterations are not as frequent as expected in advanced adenomas and are also found in non-advanced and diminutive lesions. Combining histological and molecular features in adenoma follow-up studies could increase the knowledge on malignant potential of adenomas. (1) Hermsen et al, Gastroenterology, 2002; 123:1109-1119 Citation Format: Beatriz Carvalho, Begoña Diosdado, Jochim S. Terhaar Sive Droste, Anne S. Bolijn, Meike de Wit, Myrthe van Burink, Remond JA Fijneman, Nicole CT van Grieken, Gerrit A. Meijer. Chromosomal aberrations implicated in colorectal adenoma to carcinoma progression as markers of high-risk colorectal adenomas. [abstract]. In: Proceedings of the AACR Special Conference on Colorectal Cancer: From Initiation to Outcomes; 2016 Sep 17-20; Tampa, FL. Philadelphia (PA): AACR; Cancer Res 2017;77(3 Suppl):Abstract nr A04.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 73, No. 8_Supplement ( 2013-04-15), p. 1197-1197
    Abstract: Background: Advanced adenomas are considered as an important intermediate endpoint for colorectal cancer (CRC) screening. Still the majority of these lesions do not progress to cancer. Hence, using this intermediate endpoint in evaluation of screening programs may lead to an overestimation of the effect of screening. Underlying genomic alterations like chromosomal instability characteristic of colorectal adenoma to carcinoma progression (gains of 8q, 13q, 20q and losses of 8p 15q, 18q) may more precisely mark high risk adenomas. Previously, we have shown that the presence of two or more of these particular chromosomal alterations was associated with malignant progression. The aim of this study is to evaluate the prevalence of chromosomal aberrations implicated in colorectal adenoma to carcinoma progression in advanced and non-advanced colorectal adenomas. Methods: The prevalence of DNA copy number gains and losses of 8q, 13q, 15q, 18q, 20q, 8p and 17p was determined in 65 advanced and 58 non-advanced adenomas using multiplex ligation-dependent probe amplification (MLPA). Adenomas ≥1.0 cm, with any villous features (i.e. tubulovillous or villous adenoma) or high-grade dysplasia were called advanced adenomas, while tubular adenomas, & lt;1.0 cm and with low-grade dysplasia were called non-advanced adenomas. Results: 22% of advanced adenomas showed two or more cancer associated chromosomal aberrations compared to 2% in the non-advanced adenomas. DNA copy number gain of 20q was the most frequent chromosomal aberration found in 12.2 % of the adenomas. DNA copy number gains occurred more frequently than losses. Presence of 13q and 20q gains were significantly more present in adenomas & gt;1.0 cm than & lt;1.0 cm (p=0.01 and p=0.001 respectively). 8q gain and 17p loss were significantly more present in adenomas with high degree dysplasia than with low degree dysplasia (p=0.04 and p=0.01 respectively). None of the DNA copy number changes studied was associated with the histological subtypes of advanced adenomas. Conclusions: 22% of the advanced adenomas and 2% of the non-advanced adenomas showed two or more CRC associated chromosomal aberrations. These findings are consistent with the hypothesis that the morphological parameters used to classify adenomas lack specificity as an intermediate endpoint in CRC screening. Citation Format: Begoña Diosdado, Jochim S. Terhaar sive Droste, Anne S. Bolijn, Myrthe K. van Burink, Nicole CT van Grieken, Beatriz Carvalho, Chris J. Mulder, Gerrit A. Meijer. Chromosomal aberrations implicated in colorectal adenoma to carcinoma progression as markers of high risk colorectal adenomas. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1197. doi:10.1158/1538-7445.AM2013-1197
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2013
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Gastroenterology, Elsevier BV, Vol. 142, No. 5 ( 2012-05), p. S-643-
    Type of Medium: Online Resource
    ISSN: 0016-5085
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2012
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Oncotarget, Impact Journals, LLC, Vol. 9, No. 50 ( 2018-06-29), p. 29445-29452
    Type of Medium: Online Resource
    ISSN: 1949-2553
    URL: Issue
    Language: English
    Publisher: Impact Journals, LLC
    Publication Date: 2018
    detail.hit.zdb_id: 2560162-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2019
    In:  Cancer Research Vol. 79, No. 13_Supplement ( 2019-07-01), p. 4638-4638
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 79, No. 13_Supplement ( 2019-07-01), p. 4638-4638
    Abstract: Background Chromosomal instability plays an important role in the progression of colorectal adenoma to carcinoma. We previously observed that specific non-random DNA copy number changes (8q, 13q, 20q gain, and 8p, 15q, 17p, 18q loss) were already present in the benign adenoma component of malignant polyps (i.e. adenomas with a focus of cancer). This indicates that these specific DNA copy number changes are associated with the progression from adenoma to cancer. DNA copy number dosage affects the expression of different loci, which may play an important functional role in the colorectal adenoma-to-carcinoma progression. We observed that overexpression of the miR-17-92 cluster (located on 13q) is associated with gain of 13q, one of the cancer associated DNA copy number changes. The aim of the present study was to investigate the biological meaning of miR-17-92 overexpression in benign adenomas and its role in adenoma-to-carcinoma progression. Methods Patient-derived colorectal adenoma organoids were used as model system. Two different background adenoma organoids were transduced with a miR-17-92 expression vector. Overexpression of members of the miR-17-92 cluster in the transduced adenoma organoids was confirmed by real-time quantitative RT-PCR for all individual miRNAs. Both miR-17-92-overexpressing organoids and their counterparts containing empty vectors (controls) were subjected to mRNA sequencing and subsequent differential gene expression analysis and subsequent establishement of a miR-17-92 gene expression signature. Enrichment of the miR-17-92 gene signature was evaluated in an independent series of 52 colorectal adenoma and carcinoma tissue samples. In vitro proliferation rates as well as invasion capacity of the transduced organoids were evaluated by measuring the size of the organoids and by using transwell invasion assays, respectively. Results We successfully overexpressed the miR-17-92 cluster in the two adenoma-derived organoids. Expression of 42 genes was significantly different (FDR & lt;0.05, & gt;4 fold difference) between organoids transduced with the miR-17-92 cluster and those transduced with the empty vector. In addition, in the series of 52 tumor tissue samples this gene signature could separate adenomas from carcinomas and was enriched in tumours with 13q gain. In vitro functional assays showed that proliferation capacity did not change after overexpression of the miR17-92 cluster in adenoma organoids, but capacity to invade was acquired. Conclusion We confirmed that overexpression of the miR-17-92 cluster leads to downstream gene expression alterations associated with colorectal cancer. Moreover, we showed that overexpression of this miRNA cluster promotes invasion of adenoma organoids in vitro. These results support a role of this locus in the progression from adenoma to carcinoma. Citation Format: Sanne R. Martens-de Kemp, Malgorzata A. Komor, Rosa Hegi, Marianne Tijssen, Anne S. Bolijn, Gerrit A. Meijer, Connie R. Jimenez, Remond J. Fijneman, Beatriz Carvalho. Colorectal adenoma-to-carcinoma progression: The role of miR-17-92 cluster [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4638.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2019
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: The Journal of Pathology, Wiley, Vol. 246, No. 3 ( 2018-11), p. 266-276
    Abstract: Consensus molecular subtyping is an RNA expression‐based classification system for colorectal cancer (CRC). Genomic alterations accumulate during CRC pathogenesis, including the premalignant adenoma stage, leading to changes in RNA expression. Only a minority of adenomas progress to malignancies, a transition that is associated with specific DNA copy number aberrations or microsatellite instability (MSI). We aimed to investigate whether colorectal adenomas can already be stratified into consensus molecular subtype (CMS) classes, and whether specific CMS classes are related to the presence of specific DNA copy number aberrations associated with progression to malignancy. RNA sequencing was performed on 62 adenomas and 59 CRCs. MSI status was determined with polymerase chain reaction‐based methodology. DNA copy number was assessed by low‐coverage DNA sequencing ( n  = 30) or array‐comparative genomic hybridisation ( n  = 32). Adenomas were classified into CMS classes together with CRCs from the study cohort and from The Cancer Genome Atlas ( n  = 556), by use of the established CMS classifier. As a result, 54 of 62 (87%) adenomas were classified according to the CMS. The CMS3 ‘metabolic subtype’, which was least common among CRCs, was most prevalent among adenomas ( n  = 45; 73%). One of the two adenomas showing MSI was classified as CMS1 (2%), the ‘MSI immune’ subtype. Eight adenomas (13%) were classified as the ‘canonical’ CMS2. No adenomas were classified as the ‘mesenchymal’ CMS4, consistent with the fact that adenomas lack invasion‐associated stroma. The distribution of the CMS classes among adenomas was confirmed in an independent series. CMS3 was enriched with adenomas at low risk of progressing to CRC, whereas relatively more high‐risk adenomas were observed in CMS2. We conclude that adenomas can be stratified into the CMS classes. Considering that CMS1 and CMS2 expression signatures may mark adenomas at increased risk of progression, the distribution of the CMS classes among adenomas is consistent with the proportion of adenomas expected to progress to CRC. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
    Type of Medium: Online Resource
    ISSN: 0022-3417 , 1096-9896
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2018
    detail.hit.zdb_id: 1475280-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 16, No. 5 ( 2010-03-01), p. 1391-1401
    Abstract: Purpose: The molecular pathogenesis of small intestinal adenocarcinomas is not well understood. Understanding the molecular characteristics of small bowel adenocarcinoma may lead to more effective patient treatment. Experimental Design: Forty-eight small bowel adenocarcinomas (33 non–celiac disease related and 15 celiac disease related) were characterized for chromosomal aberrations by high-resolution array comparative hybridization, microsatellite instability, and APC promoter methylation and mutation status. Findings were compared with clinicopathologic and survival data. Furthermore, molecular alterations were compared between celiac disease–related and non–celiac disease–related small bowel adenocarcinomas. Results: DNA copy number changes were observed in 77% small bowel adenocarcinomas. The most frequent DNA copy number changes found were gains on 5p15.33-5p12, 7p22.3-7q11.21, 7q21.2-7q21.3, 7q22.1-7q34, 7q36.1, 7q36.3, 8q11.21-8q24.3, 9q34.11-9q34.3, 13q11-13q34, 16p13.3, 16p11.2, 19q13.2, and 20p13-20q13.33, and losses on 4p13-4q35.2, 5q15-5q21.1, and 21p11.2-21q22.11. Seven highly amplified regions were identified on 6p21.1, 7q21.1, 8p23.1, 11p13, 16p11.2, 17q12-q21.1, and 19q13.2. Celiac disease–related and non–celiac disease–related small bowel adenocarcinomas displayed similar chromosomal aberrations. Promoter hypermethylation of the APC gene was found in 48% non–celiac disease–related and 73% celiac disease–related small bowel adenocarcinomas. No nonsense mutations were found. Thirty-three percent of non–celiac disease–related small bowel adenocarcinomas showed microsatellite instability, whereas 67% of celiac disease–related small bowel adenocarcinomas were microsatellite unstable. Conclusions: Our study characterized chromosomal aberrations and amplifications involved in small bowel adenocarcinoma. At the chromosomal level, celiac disease–related and non–celiac disease–related small bowel adenocarcinomas did not differ. A defect in the mismatch repair pathways seems to be more common in celiac disease–related than in non–celiac disease–related small bowel adenocarcinomas. In contrast to colon and gastric cancers, no APC nonsense mutations were found in small bowel adenocarcinoma. However, APC promoter methylation seems to be a common event in celiac disease–related small bowel adenocarcinoma. Clin Cancer Res; 16(5); 1391–401
    Type of Medium: Online Resource
    ISSN: 1078-0432 , 1557-3265
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 1225457-5
    detail.hit.zdb_id: 2036787-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...